Diagnostics Market Research Reports and Industry Size, Share

Atherosclerosis - Pipeline Review, H1 2015

Jun-2015 | Global Markets Direct | Pages : 276 | Code : MRS-26112 | 2000

Atherosclerosis - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Atherosclerosis - Pipeline Review, H1 2015’, provides an overview of the Atherosclerosis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Atherosclerosis, com Read more

Renal Cell Carcinoma - Pipeline Review, H1 2015

Jun-2015 | Global Markets Direct | Pages : 609 | Code : MRS-26111 | 2000

Renal Cell Carcinoma - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Renal Cell Carcinoma - Pipeline Review, H1 2015’, provides an overview of the Renal Cell Carcinoma’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Renal Read more

Global Vitamin D Testing Market 2015-2019

Jul-2015 | Technavio | Pages : 72 | Code : MRS-25573 | 2500

About Vitamin D Testing Vitamin D is a naturally occurring, fat-soluble, biologically inert hormone precursor that exists in two primary forms: vitamin D2 (ergocalciferol) and vitamin D3 (cholecalciferol). Its main biologic function is to maintain calcium and phosphorus concentrations as it is Read more

Global TB Diagnostic Market 2015-2019

Jul-2015 | Technavio | Pages : 82 | Code : MRS-25572 | 2500

About TB Diagnostics TB is an infectious bacterial disease caused by Mycobacterium tuberculosis. It is communicable and can be transmitted from one person to another. TB is one of the world’s deadliest communicable diseases. In 2013, there were 9 million new TB cases and 1.5 million TB deaths, Read more

Global Genetic Testing Market 2015-2019

Jul-2015 | Technavio | Pages : 82 | Code : MRS-25571 | 2500

About Genetic Testing Genetic testing is the most profitable and rapidly expanding segment of molecular diagnostics. It is the array of techniques used for the analysis of DNA, RNA, and protein. It is used as a medical tool to determine the genetic defects associated with a particular disease Read more

Global Radiotherapy Market Outlook (2014-2022)

Jun-2015 | Stratistics MRC | Pages : 90 | Code : MRS-25452 | 4150

Global Radiotherapy Market is estimated to be $6.1 billion in 2014 with CAGR of 6.65% is expected to reach $10.2 billion by 2022. The global radiotherapy market is a widely growing sector in recent years and is driven by factors such as increasing number of cancer pat Read more

Chondrosarcoma - Pipeline Review, H1 2015

Jun-2015 | Global Markets Direct | Pages : 98 | Code : MRS-25363 | 2000

Chondrosarcoma - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Chondrosarcoma - Pipeline Review, H1 2015’, provides an overview of the Chondrosarcoma’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Chondrosarcoma, complet Read more

Gliosarcoma - Pipeline Review, H1 2015

Jun-2015 | Global Markets Direct | Pages : 62 | Code : MRS-25362 | 2000

Gliosarcoma - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Gliosarcoma - Pipeline Review, H1 2015’, provides an overview of the Gliosarcoma’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Gliosarcoma, complete with compa Read more

Refractory Leukemia - Pipeline Review, H1 2015

Jun-2015 | Global Markets Direct | Pages : 41 | Code : MRS-25361 | 2000

Refractory Leukemia - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Refractory Leukemia - Pipeline Review, H1 2015’, provides an overview of the Refractory Leukemia’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Refracto Read more

Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015

Jun-2015 | Global Markets Direct | Pages : 247 | Code : MRS-25360 | 2000

Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015’, provides an overview of the Relapsed Chronic Lymphocytic Leukemia (CLL)’s therapeutic pipeline. This report provid Read more

1220 Out of 1373 Records